By John Evans, Associate Editor, Derm.cityJul 11, 20174 minTrials show dupilumab effective, safe for moderate to severe ADThe SOLO 1 and SOLO 2 phase 3 trials of the human monoclonal anti-body dupilumab for the treatment of eczema/atopic dermatitis (AD) have...
by Lynn Bradshaw, Senior EditorJun 27, 20172 minStudy casts doubt about link between eczema, cardiovascular diseaseData suggests that there appears to be no associated link between atopic dermatitis (AD) and cardiovascular disease, a finding that is...
by Lynn Bradshaw, Senior EditorJun 15, 20172 minStress levels before pregnancy could influence risk of eczema in offspringResearch from the U.K. suggests that the stress levels of women prior to conception may increase their offspring’s risk of atopic eczema,...
by John Evans, Associate EditorMay 5, 20172 minFilaggrin deficiency’s ties to eczema clarifiedResearchers from Newcastle University, U.K., in collaboration with scientists at Stiefel, a GSK company, have identified how the skin...